ZYPREXA |
OLANZAPINE |
LY170053 |
LY-170053 |
ARKOLAMYL |
ZYPREXA ZYDIS |
ZALASTA |
pubchem.compound:4585 |
OLANZAPINUM |
OLANZAPINA |
2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-B][1,5]BENZODIAZEPINE |
OLANZAPIN |
drugbank:00334 |
chemidplus:132539-06-1 |
chembl:CHEMBL715 |
rxcui:61381 |
Drug Indications | antidepressant,for treatment of bipolar disorder |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antipsychotic agent |
Year of Approval | 1996 |
Drug Class | antipsychotic agents |
agonist (activating) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Mechanism of Interaction | Serotonin 2c (5-HT2c) receptor antagonist |
Direct Interaction | yes |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
agonist (activating) |
antagonist (inhibitory) |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Direct Interaction | yes |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Direct Interaction | yes |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
antagonist (inhibitory) |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Direct Interaction | yes |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
agonist (activating) |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
agonist (activating) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Novel drug target | Established target |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
agonist (activating) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | ALKS 3831 |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
antagonist (inhibitory) |
Trial Name | olanzapine,Zyprexa, Zypadhera, Zyprexa Relprevv |
Novel drug target | Established target |
Trial Name | Olanzapine/fluoxetine combination,Symbyax (Zyprexa/Prozac) |
OLANZAPINE | Primary Drug Name |
Drug Class | antipsychotic agents |
Year of Approval | 1996 |
Drug Indications | antipsychotic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
D0V4QS | TTD Drug ID |
CHEMBL715 | ChEMBL Drug ID |